<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Nankai_project_background skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Nankai/project background</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Medigo Blue, free responsive template</TITLE></P><DIV class="responsive_menu"><UL class="main_menu"><LI><A href="https://2015.igem.org/Team:Nankai">Home</A></LI><LI><A href="#">Research &amp; Lab</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Description">Project</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Safety">Safety</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Measurement">Measurements</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Parts">Parts</A></LI></UL><LI><A href="#">Member</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Team">Team</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Attributions">Attributions</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Collaborations">Collaborations</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Practices">Human Practices</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Modeling">Modeling</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Practices/iShare" target="_blank">iShare</A></LI></DIV><HEADER class="site-header"><DIV><DIV><DIV><DIV class="main-navigation"><NAV class="main-nav visible-md visible-lg"><UL class="sf-menu"><LI id="sideli"><A href="https://2015.igem.org/Team:Nankai/Practices/iShare" target="_blank">iShare</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Modeling">Modeling</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Practices">Human Practices</A></LI><LI><A href="#">Member</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Team">Team</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Attributions">Attributions</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Collaborations">Collaborations</A></LI></UL><LI><A href="#">Research &amp; Lab</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Description">Project</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Safety">Safety</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Measurement">Measurements</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Parts">Parts</A></LI><LI><A href="https://2015.igem.org/Team:Nankai">Home</A></LI></NAV><DIV class="hidemenu"><P><A href="#">menu</A></P></DIV></DIV></DIV></DIV></DIV></HEADER><DIV class="first-widget parallax" id="blog"><DIV class="parallax-overlay"><P>Your place: <A href="https://2015.igem.org/Team:Nankai">Home</A> &gt; <A href="https://2015.igem.org/Team:Nankai/Description">Project</A> &gt; <A href="https://2015.igem.org/Team:Nankai/project_background">Background</A></P><DIV class="container pageTitle"><DIV class="row"><DIV class="col-md-6 col-sm-6"><H2 class="page-title">Project Background</H2></DIV></DIV></DIV></DIV></DIV><DIV class="container"><DIV class="row"><DIV class="col-md-8 blog-posts"><H4>1. Pudding health kit — Wound healing hydrogel based on γ-PGA</H4><P>Poly-γ-glutamic acid (γ-PGA) is a naturally occurring biopolymer that is water soluble, non-toxic, edible, and biodegradable, which has shown to promote cell migration and enhance cell adhesion. Besides, γ-PGA has been reported to prevent postsurgical tissue adhesion and the γ-PGA drug-loaded hydrogel to promote wound healing.</P><H6>Figure 1. Appearance and structural formula of γ-PGA.</H6><P>We prepared two types of SOD-PGA hydrogels for wound healing. γ-PGA hydrogel had high water absorption properties delivering the important moist environment. SOD released from the hydrogel maintained high enzyme activity and SOD-PGA hydrogels could scavenge the superoxide anion effectively. In vivo results showed that SOD-PGAS/PGA-H could promote collagen deposition, epithelialization, and accelerate the healing of moderately exuding wounds. Therefore, SOD-PGA hydrogels would be a good candidate for wound healing applications.<A href="https://2015.igem.org/Team:Nankai/Design">Learn about more here.</A></P><H6>Figure 2. MCS/γ-PGA mixture in solution (A). MCS/γ-PGA hydrogel (B). Microstructure of γ-PGAS/PGA hydrogel (C, D)</H6><H4>2. γ-PGA producing strain — <EM>Bacillus amyloliquefaciens</EM> LL3</H4><P>Strains capable for producing γ-PGA are divided into two categories based on their requirement for glutamate acid: glutamate-dependent strains and glutamate-independent strains. Glutamate-independent strains are preferable for industrial production because of their low cost and simplified fermentation process. However, compared with glutamate-dependent strains, their lower γ-PGA productivity limits their industrial application. Therefore, the construction of a glutamate-independent strain with high γ-PGA yield is important for industrial applications. </P><H6>Figure 3. Stereoscan photograph of <EM>B.amyloliquefaciens</EM> LL3 strain</H6><P><EM>B. amyloliquefaciens</EM> strains are ubiquitous in the soil and are great reservoirs of important natural products, such as α-amylase, levansucrase, and fibrinolytic enzymes. Besides important cell factories, <EM>B. amyloliquefaciens</EM> strains are also used as plant growth-promoting and bio-control bacteria partly due to their ability to produce substances with antifungal, antibacterial and nematocidal activities. <EM>B. amyloliquefaciens</EM> LL3, isolated from fermented food, is a glutamate-independent strain, which can produce γ-PGA with sucrose as its carbon source and ammonium sulfate as its nitrogen source.
</P><H4>3. Methods to increase poly-γ-glutamic acid production</H4><P>In this study, we aimed to improve the γ-PGA production based on the <EM>B. amyloliquefaciens</EM> NK-1 strain (a derivative of LL3 strain with its endogenous plasmid and <EM>upp</EM> gene deleted). In order to improve γ-PGA production, we employed two strategies to fine-tune the synthetic pathways and balance the metabolism in the glutamate-independent <EM>B. amyloliquefaciens</EM> NK-1 strain.</P><H5>3.1 Metabolic toggle switch</H5><H6>Figure 4. Biosynthetic pathway of poly-γ-glutamic acid. Red arrows shows the metabolic flux towards γ-PGA synthesis. The blue arrow is the leakage of metabolic flux.</H6><P>Firstly, we aimed to increase the intracellular concentration of γ-PGA precursor-- glutamate. In <EM>B. amyloliquefaciens</EM>,2-oxoglutarate is very important for the synthesis of glutamate, yet large amount of 2-oxoglutarate is consume by TCA cycle to turn into succinl-CoA in the action of enzyme ODHC (2-oxoglutarate dehydrogenase complex). Scientists had found that the activity of ODHC was rather low when glutamate was highly produced in a <EM>Corynebacterium glutamicum</EM> strain. This made us wonder, could we be able to increase the amount of intracellular glutamate by inhibiting the expression of ODHC at the stationary phase in <EM>B. amyloliquefaciens</EM>? Therefore, we constructed a metabolic toggle switch in the NK-1 strain to inhibit the expression of ODHC by adding IPTG in the stationary stage, trying to distribute the metabolic flux more frequently to be used for γ-PGA precursor-glutamate synthesis.</P><H6>Figure 5. Metabolic toggle switch to regulate the expression of ODHC.</H6><P>Without IPTG, the promoter Pgrac is inhibited by suppressor LacI and the supreessor XylR will not synthesized, thus the promoter Pxyl is active and <EM>odhAB</EM> genes are expressed. When IPTG is added, the <EM>xylR</EM> gene is expressed and the suppressor XylR is synthesized thereafter inhibited the expression of <EM>odhAB</EM> genes.</P><H5>3.2 Replacement of promoters</H5><P>Secondly, to balance the increase of endogenous glutamate production, we optimized the expression level of <EM>pgsBCA</EM> genes (responsible for γ-PGA synthesis) by replacing its native promoter with six different strength promoters.</P><H6>Figure 6.Genes responsible for γ-PGA synthesis</H6><P>Through these two strategies, we aimed to obtain a γ-PGA production improved mutant strain.</P></DIV><DIV class="col-md-4"><DIV class="sidebar"><DIV class="sidebar-widget"><H6><A href="https://2015.igem.org/Team:Nankai/Description">Description</A></H6><H6><A href="https://2015.igem.org/Team:Nankai/project_background">Background</A></H6><H6><A href="https://2015.igem.org/Team:Nankai/Experiments">Experiments &amp; Protocols</A></H6><H6><A href="https://2015.igem.org/Team:Nankai/Results">Results</A></H6><H6><A href="https://2015.igem.org/Team:Nankai/Design">Design - Pudding Health Kit</A></H6></DIV><DIV class="sidebar-widget"><P>These are all bioreactors used for fermentation.</P><P>Electroosmosis.</P><P>Chromosome of bacillus amyloliquefaciens LL3.</P><P>Ready for doing PCR.</P></DIV></DIV></DIV></DIV></DIV><TITLE>Medigo Blue, free responsive template</TITLE><FOOTER class="site-footer"><DIV class="copyright-content"><DIV class="copyright-text"><P>Copyright © Nankai University </P><P> Nankai IGEM Team 2015</P></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></BODY></HTML>